Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
Clinical trial NCT04918186 · RECRUITING
Trial details
- NCT number
- NCT04918186
- Sponsor
- Canadian Cancer Trials Group
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-03
- Primary completion
- 2026-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.